[{"data":1,"prerenderedAt":63},["ShallowReactive",2],{"q-nurse-108-1-medical-surgical-050":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":35,"lastmod":62},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-108-1-內外科護理學-050","nurse-108-1-medical-surgical-050",108,1,50,"有關細胞性免疫之敘述，下列何者正確？",{"A":14,"B":15,"C":16,"D":17},"主導細胞為 B 細胞","主要作用為保護個體不受感染","形成免疫反應所需時間，較體液性免疫反應時間短","T 細胞須藉由主要組織相容複合物為媒介","D",null,[],"本題考點在於細胞性免疫的特性與 T 細胞辨識抗原的機制。依免疫學，T 細胞無法直接辨識游離抗原，必須經主要組織相容複合物（MHC）呈現抗原片段才能活化，故選 D。（A）錯在細胞性免疫的主導細胞為 T 細胞，B 細胞屬體液性免疫。（B）錯在「保護個體不受感染」以中和病原、對抗細胞外微生物為主，是體液性免疫（抗體）的作用；細胞性免疫主攻細胞內病原、病毒感染細胞與腫瘤。（C）錯在細胞性免疫屬遲發反應，形成免疫反應所需時間較體液性免疫長，而非較短。","抗原呈現規則：MHC-I 呈現內源性抗原給細胞毒性 T 細胞（CD8），MHC-II 呈現外源性抗原給輔助性 T 細胞（CD4）。記憶「八乘一、四乘二等於八」對應 CD8-MHCI、CD4-MHCII。細胞性免疫負責清除病毒感染細胞、腫瘤、移植排斥與遲發型（IV 型）過敏，故結核菌素試驗需 48–72 小時。體液性免疫靠 B 細胞漿細胞分泌抗體，反應相對快。連結概念：CD4／CD8、MHC 限制、遲發型過敏、細胞毒性 T 細胞。",[24,27,29,31,33],{"term":25,"count":26},"細胞性免疫",2,{"term":28,"count":10},"T 細胞",{"term":30,"count":10},"主要組織相容複合物 MHC",{"term":32,"count":10},"抗原呈現",{"term":34,"count":10},"遲發型免疫反應",[36,40,44,48,53,58],{"webId":37,"stem":38,"number":39,"year":9,"session":10},"nurse-108-1-medical-surgical-051","有關膿胸病變發生之部位，下列何者正確？",51,{"webId":41,"stem":42,"number":43,"year":9,"session":26},"nurse-108-2-medical-surgical-067","有關糖尿病酮酸中毒（DKA）之處置，下列何者錯誤？",67,{"webId":45,"stem":46,"number":10,"year":47,"session":26},"nurse-109-2-medical-surgical-001","有關顱內壓升高的處置，下列敘述何者正確？",109,{"webId":49,"stem":50,"number":51,"year":52,"session":26},"nurse-110-2-medical-surgical-039","有關化學治療特性的敘述，下列何者正確？",39,110,{"webId":54,"stem":55,"number":56,"year":57,"session":10},"nurse-112-1-medical-surgical-003","有關多發性硬化症病人的自我照顧之護理指導，下列敘述何者錯誤？",3,112,{"webId":59,"stem":60,"number":61,"year":57,"session":56},"nurse-112-3-medical-surgical-037","有關慢性阻塞性肺疾病（COPD）病人的護理照護計畫，下列何者應列為最優先處理？",37,"2026-09-04",1788510709952]